Showing results (1-10 of 196) with videos related to
Sort By:
Pageof 20
Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons|September 4, 2004
Long-term outcomes after total alloplastic temporomandibular joint reconstruction following exposure to failed materialsLouis G Mercuri, Anita Giobbie-HurderClinical Trials (London, England)|June 17, 2009
Design, conduct, and analyses of Breast International Group (BIG) 1-98: a randomized, double-blind, phase-III study comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with receptor-positive, early breast cancerAnita Giobbie-Hurder, Karen N Price, Richard D Gelber, et al.Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons|May 23, 2007
Fourteen-year follow-up of a patient-fitted total temporomandibular joint reconstruction systemLouis G Mercuri, Naushad R Edibam, Anita Giobbie-HurderInvestigational New Drugs|April 25, 2023
A phase I/II study of MCS110 with BRAF/MEK inhibition in patients with melanoma after progression on BRAF/MEK inhibitionElizabeth I Buchbinder, Anita Giobbie-Hurder, Patrick A OttJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2013
Challenges of guarantee-time biasAnita Giobbie-Hurder, Richard D Gelber, Meredith M ReganInvestigational New Drugs|May 29, 2023
A phase I/II study of LY3022855 with BRAF/MEK inhibition in patients with MelanomaElizabeth I Buchbinder, Anita Giobbie-Hurder, Rizwan Haq, et al.Journal for Immunotherapy of Cancer|November 21, 2014
Response assessment in metastatic melanoma treated with ipilimumab and bevacizumab: CT tumor size and density as markers for response and outcomeMizuki Nishino, Anita Giobbie-Hurder, Nikhil H Ramaiya, et al.Kidney International|March 13, 2003
Low protein diet mediated renoprotection in remnant kidneys: Renal autoregulatory versus hypertrophic mechanismsKaren A Griffin, Maria Picken, Anita Giobbie-Hurder, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2012
The activation of MAPK in melanoma cells resistant to BRAF inhibition promotes PD-L1 expression that is reversible by MEK and PI3K inhibitionXiaofeng Jiang, Jun Zhou, Anita Giobbie-Hurder, et al.Plos One|January 19, 2012
The protein kinase C inhibitor enzastaurin exhibits antitumor activity against uveal melanomaXinqi Wu, Meijun Zhu, Jonathan A Fletcher, et al.Pageof 20